Cargando…
Probiotic for Pancreatic β-Cell Function in Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
INTRODUCTION: Many clinical studies have proved the effectiveness of probiotics in metabolic disorders associated with insulin resistance. However, the impact of probiotic therapy on pancreatic β-cell function is ambiguous. The influence of probiotic supplementation vs. placebo on β-cell function in...
Autores principales: | Savytska, Maryana, Kyriienko, Dmytro, Komisarenko, Iuliia, Kovalchuk, Oleksandr, Falalyeyeva, Tetyana, Kobyliak, Nazarii |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570251/ https://www.ncbi.nlm.nih.gov/pubmed/37713103 http://dx.doi.org/10.1007/s13300-023-01474-6 |
Ejemplares similares
-
Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity
por: Savcheniuk, Oleksandr, et al.
Publicado: (2014) -
Antimicrobial activity of dietary supplements based on bacterial lysate of Lactobacillus rhamnosus DV
por: Penchuk, Yurii, et al.
Publicado: (2023) -
Pathophysiological role of host microbiota in the development of obesity
por: Kobyliak, Nazarii, et al.
Publicado: (2016) -
Crosstalk between gut microbiota and antidiabetic drug action
por: Kyriachenko, Yevheniia, et al.
Publicado: (2019) -
Efficacy and safety of fecal microbiota transplantation via colonoscopy as add-on therapy in patients with mild-to-moderate ulcerative colitis: A randomized clinical trial
por: Tkach, Sergii, et al.
Publicado: (2023)